GL1X · GenesisL1 explorer

MolNFT v1 · #119287 · protein

ALK5 in complex witha an N-(4-anilino-2-PYRIDYL)ACETAMIDE inhibitor.

5FRI · TGF-beta receptor type-1: “ALK5 in complex witha an N-(4-anilino-2-PYRIDYL)ACETAMIDE inhibitor.”. X-ray diffraction, 1 ligand (ZUQ), 4 pockets (best druggability 0.75). MolNFT v1 #119287 on GenesisL1: 3D structure, binding sites and…

PDB
5FRI
Type
protein
Length
301 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
TGF-beta receptor type-1
EC
2.7.11.30
UniProt
P36897
Ligands
ZUQ
Pockets
4 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATGF-beta receptor type-1 (EC 2.7.11.30)protein30139% helix, 21% strandP36897

Ligands and binding sites

  • ZUQ · N-[4-[(6-chloro-[1,3]dioxolo[4,5-b]pyridin-7-yl)amino]-2-pyridyl]cyclopropanecarboxamide · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1670.750.9920empty
22780.690.8437ZUQ
3610.420.8223empty
4530.290.7512empty

Compared structures

  • 5FRI · ALK5 in complex witha an N-(4-anilino-2-pyridyl)acetamide inhibitor. · the same entry in another collection · chain A against A, TM-score 1.00
  • P36897 · AlphaFold monomer V2.0 prediction for TGF-beta receptor type-1 (P36897) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.